However, ongoing research on therapies for obesity-associated NAFLD includes diet and lifestyle modification for weight loss, the use of the supplements and insulin sensitizers, and surgery [25]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.